Lantheus Alpha Therapy, LLC
CIK 2010224 · last filed 2026-09-04
Lantheus Alpha Therapy, LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider sold $357.2K of CATX on Sep 4, 2026. Across all open-market trades the lifetime net is −$619.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $36.3M across reported positions. The firm reports its address in Bedford, MA. 2 SEC filings were submitted jointly with Lantheus Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.31M
1
2
-$619.6K
Filer Profile
201 BURLINGTON ROAD, SOUTH BUILDING
BEDFORD, MA 01730
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | 10%+ Owner | 11,599,194 | $3.13 | $36.31M | -$619.6K | 2 | 2026-09-04 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-04 | CATX | Sell (S) | −113,914 | -$357.2K | EDGAR |
| 2026-09-04 | CATX | Sell (S) | −84,258 | -$262.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.